RDB01902 - pSK II+PSApr

Please review the QC test results indicated by check

icon below as well as clone information before placing your order.

pSK II+PSApr (#RDB01902)

Human PSA promoter/enhancer genomic DNA

Clone info.	Prostate specific antigen promoter/enhancer
Vector backbone	pBluescript II SK (+) (Plasmid)
Size of vector backbone	3.0 kb
Selectable markers	Amp^r
Gene/insert name	Human kallikrein-related peptidase 3 Genomic DNA
Depositor\|Developer	Hamada, Hirofumi \|

Additional map

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.

Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link]

Terms and conditions for distribution The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.

提供案内 (日本国内) [open/close]

Ordering forms	Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link]
Terms and conditions for distribution	The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.

必要書類	提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件	非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。

必要書類

提供依頼書

[依頼書の記入例

]
提供同意書 (MTA, 非営利学術目的用)[Word

] [MTAの記入例

]
手続きの概要は、「提供申込みについて[link]」をご覧ください。

MTAに書く使用条件

非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。

Catalog #	Resource name	Shipping form	Fee (non-profit org.)
RDB01902	pSK II+PSApr	DNA solution	Please contact us.

Please review the QC test results indicated by check

icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pSK II+PSApr was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB01902).

Reference section:

Further references such as user reports and related articles (go to bottom)

QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet	RDB12757_A4Df.pdf

Nucleotide sequence of a portion of this resource (if available).

Primer: M13_-40 Sequence file: RDB12757_A4Dfa.seq
>01902_12757_A4Df_M13(-40)_A01_01.ab1 1 CGGACCGGTG ACGGCGCGTA TACGACTCAC TATAGGGCGA ATTGGGTCAC CGGGCCCCCC 61 CTCGAGGTCG ACGGTATCGA TAAGCTTGGG GCTGGGGAGC CTCCCCCAGG AGCCCTATAA 121 AACCTTCATT CCCCAGGACT CCGCCCCTGC CCTGCTGGCA CCCAGAGGCT GACCAAGGCC 181 CTCCCCATGC TGCTGGAGGC TGGACAACCC CCTCCCACAC CCAGAGCTGT GGAAGGGGAG 241 GGAGAGCTAG TACTTGCTGT TCTGCAATTA CTAGATCACC CTGGATGCAC CAGGCCCTGT 301 AGCTCATGGA GACTTCATCT AGGGGACAAA GGCAGAGGAG ACACGCCCAG GATGAAACAG 361 AAACAGGGGG TGGGTACGAT CCCCGATTCT TCATACAAAG CCTCACGTGC CTAGATCCTT 421 TGCACTCCAA GACCCAGTGT GCCCTAAGAC ACCAGCACTC AGGAGATTGT GAGACTCCCT 481 GATCCCTGCA CCACTCTGAG ACCAGAAACT AGAACTTTTA TTCCTCATGC TCCTGAAATA 541 GATGTCTTGG CATTTAGTAC ATTCTTTTCC TTGCACTCCC AACCCAGAAT CCAGCTCCAC 601 AGATACATTG CTACTGTCAT CATAAAAAGA TCTTGTGGTC CACAGATCCT CTAGCCCAGA 661 AATATGAGTC TCCCAAAGTT CCCTAGCATT TCAAAATCCA ACGTGCAGCA AACAATGTGG 721 AATTCTCCAT GGTTCTGTCA CGTATCTGTG TGTCTTCTGA GCAAAGACAG CAACACCTTT 781 TTTTTTCTGG ATTGTTGTTT CAAGGATGTT TGTAAAGCAG GCATCCTTGC AAGATGATAT 841 CTCTCTCAGA TCCAGGCTTG CTTACTGTCC TAGATAATAA AGATAATGTC TCTTACAACA 901 GATTTGTTTA CTGTCAAGGA CAATCGATAC AATATGTTCC TCCAGAGTAG GTCTGTTTTC 961 AATCCAAGAT CATGAAGATA ATATCTTCAT CAGAGACAAA GGCTGAGCAG GTTTGCAAGT 1021 TTGTCCCAGT ATAAGATTGA GGATTCCCTA ATCTCAGGTT TTCTCACCAG TGGCACAAAC 1081 CCCGTGTGCA CAGCATCCAC CTAGACTGCT CTGTTCACCT TACCAGGATT TGGGGGGGGG 1141 GCAGGTGCTA CTAATTGTTG AAACATGAAA CCCCTCCA //
Primer: Reverse2 Sequence file: RDB12757_A4Dfb.seq
>01902_12757_A4Df_Reverse2_B01_04.ab1 1 GGATACCGGC ATTACGCCAG CGCGCAATTA ACCCTCACTA AAGGGAACAA AAGCTGGAGC 61 TCCACCGCGG TGGCGGCCGC TCTAGAAATC TAGCTAATAT AGTGTGGCTC AAAACCTTCA 121 GCACAAATCA CACCGTTAGA CTATCTGGTG TGGCCCAAAC CTTCAGGTGA ACAAAGGCAC 181 TCTAATCTGG CAGGATATTC CAAAGCATTA GAGATGACCT CTTGCAAAGA AAAAGAAATG 241 GAAAAGAAAA AGAAAGAAAG GAAAAAAAAA AAAAAGAGAT GACCTCTCAG GCTCTGAGGG 301 GAAACGCCTG AGGTCTTTGA GCAAGGTCAG TCCTCTGTTG CACAGTCTCC CTCACAGGGT 361 CATTGTGACG ATCAAATGTG GTCACGTGTA TGAGGCACCA GCACATGCCT GGCTCTGGGG 421 AGTGCCGTGT AAGTGTATGC TTGCACTGCT GAATGGCTGG GATGTGTCAG GGATTATCTT 481 CAGCACTTAC AGATGCTCAT CTCATCCTCA CAGCATCACT ATGGGATGGG TATTACTGGC 541 CTCATTTGAT GGAGAAAGTG GCTGTGGCTC AGAAAGGGGG GACCACTAGA CCAGGGACAC 601 TCTGGATGCT GGGGACTCCA GAGACCATGA CCACTCACCA ACTGCAGAGA AATTAATTGT 661 GGCCTGATGT CCCTGTCCTG GAGAGGGTGG AGGTGGACCT TCACTAACCT CCTACCTTGA 721 CCCTCTCTTT TAGGGCTCTT TCTGACCTCC ACCATGATAC TAGGACCCCA TTGTATTCTG 781 TACCCTCTTG ACTCTATGAC CCCCACTGCC CACTGCATCC AGCTGGGTCC CCTCCTATCT 841 CTATTCCCAG CTGGCCAGTG CAGTCTCAGT GCCCACCTGT TTGTCAGTAA CTCTGAAGGG 901 GCTGACATTT TACTGACTTG CAAACAAATA AGCTAACTTT ACAGAGTTTT GTGAATGCTG 961 GCAGAGTCCA TGAGACTCCT GAGTCAGAGG CAAGGGCTTT TACTGCTCAC AGCTTAGCAG 1021 ACAGCATGAG TTCATGTTTC ACATTTAGTA CACCTTGCCC CCCCCCCAAA ATCTTGTAGG 1081 TGACCAGAGC CAGTCCTAAG TGGATGCTGT GCACACGGGT TGTGCCACTG ATGAGAAACC 1141 TGGAGATAGC AATTCCTCAA TTCTTAATTA CTTG //